-
公开(公告)号:KR840001287B1
公开(公告)日:1984-09-07
申请号:KR840002710
申请日:1984-05-18
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , NAGANO MASANOBU , KATO MASAYUKI
IPC: C07D239/86 , C07D487/04 , C07D487/14
-
公开(公告)号:KR840001315B1
公开(公告)日:1984-09-11
申请号:KR840002711
申请日:1984-05-18
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , KATO MASAYUKI , NAGANO MASANOBU
IPC: C07D239/86 , C07D487/04 , C07D487/14
-
公开(公告)号:KR840001040B1
公开(公告)日:1984-07-26
申请号:KR840002712
申请日:1984-05-18
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , NAGANO MASANOBU , KATO MASAYUKI
IPC: C07D239/86 , C07D487/04 , C07D487/14
-
公开(公告)号:JPH1192432A
公开(公告)日:1999-04-06
申请号:JP13016798
申请日:1998-05-13
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: SHIOKAWA YOICHI , NAGANO MASANOBU , TANIGUCHI KIYOSHI , TAKE KAZUHIKO , KATO TAKESHI , TSUBAKI KAZUNORI
IPC: A61K31/13 , A61K31/135 , A61K31/19 , A61K31/24 , A61K31/275 , A61K31/34 , A61K31/341 , A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/42 , A61K31/4245 , A61K31/425 , A61K31/426 , A61K31/428 , A61K31/433 , A61K31/47 , A61P7/10 , A61P25/02 , C07C215/08 , C07C215/14 , C07C215/16 , C07C215/30 , C07C215/64 , C07C217/74 , C07C219/30 , C07C227/18 , C07C229/16 , C07C229/18 , C07C229/32 , C07C229/42 , C07C229/44 , C07C229/46 , C07C235/20 , C07C255/26 , C07C323/25 , C07D209/04 , C07D209/48 , C07D213/61 , C07D215/12 , C07D235/14 , C07D253/00 , C07D257/02 , C07D261/08 , C07D271/06 , C07D271/08 , C07D271/10 , C07D271/12 , C07D277/20 , C07D277/62 , C07D285/04 , C07D307/52 , C07D317/58 , C07D487/04 , C07D521/00
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound useful as a medicine for treating and/or preventing dysuria, convulsion or hyperanakinesia in human or animal. SOLUTION: This compound is represented by formula I [R is an aryl (substituted with a halogen, OH or the like) or a heterocyclic group; R is H, a halogen, nitro or the like; R is H, an N-protecting group or the like; (n) is 0-3; bold full line is a single bond or double bond, with the proviso that when (n) is 1, R is a heterocyclic group (e.g. substituted with a halogen, OH, or the like) or the like or R is a halogen, nitro or the like or R is an N- protecting group or the like or bold full line is double bond], e.g. (1R,6'S)-2-[(3- ethoxycarbonylmethoxy-6,7,8,9-tetrahydro-5H-benzocyclopenten-6-yl)amin o]-1-(3- chlorophenyl)ethanol hydrochloride. The compound of formula I is obtained by reacting, e.g. a compound of formula II with a compound (salt) of formula III.
-
公开(公告)号:JPH08231516A
公开(公告)日:1996-09-10
申请号:JP1640696
申请日:1996-02-01
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: NAGANO MASANOBU , TAKENAKA KOHEI , KATO TAKESHI , KOBAYASHI YUIKO
IPC: C12N9/99 , A61K31/55 , A61P9/00 , A61P9/12 , A61P43/00 , C07D243/02 , C07D405/12
Abstract: PURPOSE: To obtain a new compound having an activity for inhibiting neutral endpeptidase and angiotensin transferase, and useful for hypertension, cardiac failure, angina pectoris, renal failure, periodic edema, aldosteronism, hypercalcemia, glaucoma, asthma, inflammation, ache, epilepsia, etc. CONSTITUTION: A compound of formula I [R is an acyl; a (protected)mercapto; R is H, a (substituted)aryl; R is a (substituted)acyl lower alkyl; R is a lower alkyl, a cyclo lower alkyl, a (substituted)aryl; X is a lower alkylene; Y is a single bond, C(=O); Z is a lower alkylene; R is H, a lower alkyl; R is H, or R and R are combined with each other to form a single bond]. For example, [(S)-6-((S)-2-acetylthio-3-phenylpropionyl)amino-4,5,6,7-tetrahydro-7- oxo-3- phenyl-1H-1,2-diazepin-1-yl]acetic acid ethyl ester. The compound of formula I is obtained by reacting a compound of formula II with a compound of formula III.
-
公开(公告)号:JPH0466867B2
公开(公告)日:1992-10-26
申请号:JP9722584
申请日:1984-05-14
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , NAGANO MASANOBU , AKAHA ATSUSHI
IPC: C07D213/56 , C07D213/57
-
公开(公告)号:JPH0124145B2
公开(公告)日:1989-05-10
申请号:JP21931583
申请日:1983-11-21
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , NAGANO MASANOBU , AKAHA ATSUSHI
IPC: C07D213/56 , A61K31/44 , A61K31/4402 , A61K31/4418 , A61P1/04 , C07D213/57
-
公开(公告)号:JPS5695174A
公开(公告)日:1981-08-01
申请号:JP17045980
申请日:1980-12-03
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , KATOU MASAYUKI , NAGANO MASANOBU
IPC: C07D239/94 , A61K31/505 , A61K31/517 , A61P37/08 , C07D239/95 , C07D405/12 , C07D487/04 , C07D487/14
Abstract: NEW MATERIAL:A compound shown by the formula I [Ra and Rb are esterified carboxyl group; R and R are H, alkyl, halogen, nitro, amino, alkoxy, etc.; A' is a group shown by the formula II (R is H, alkyl, OH, dialkylamino, etc.), or a group shown by the formula III (R is alkyl or alkenyl)], a pyrimidoquinazoline compound shown by the formula IV (R is H, carboxy, etc.; A is a group shown by the formula III, etc.), or their pharmaceutically acceptable salts. EXAMPLE:Diethyl [(6-pivalamide-4-quinazolinylamino)methylene]-propanedioate. USE:An antiallergic agent, e.g., a drug for allergic asthma. PROCESS:A compound shown by the formula V is reacted with a compound shown by the formula VI (R is alkoxy) to give a compound shown by the formula I.
-
公开(公告)号:JPH05294946A
公开(公告)日:1993-11-09
申请号:JP20154191
申请日:1991-05-09
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: UEDA IKUO , KATO MASAYUKI , NAGANO MASANOBU
IPC: A61K31/505 , A61K31/517 , A61P37/08 , C07D239/74 , C07D239/80 , C07D239/94 , C07D239/95 , C07D239/96 , C07D265/26 , C07D405/12 , C07D487/04 , C07D487/14
Abstract: PURPOSE:To provide the subject new compound exhibiting a strong antiallergic effect and useful as a low-toxic antiallergic agent. CONSTITUTION:A compound of formula I [R a and R b are each an esterified carboxyl or a group of formula II may be formed in combination of R a with R b; R and R are each H, an alkyl, a halogen, nitro, amino, etc.; A' is formula III (R is H, an alkyl, hydroxyl, etc.) or formula IV (R is an alkyl)], e.g. diethyl[(4-quinazolinylamino)-methylene] propanedioate. The compound of formula I is obtained by reacting a compound of formula V with a compound of formula VI (R is an alkoxy) in a solvent such as N,N-dimethylformamide under cooling or heating. Useful for allergic asthma, allergic rhinitis, uticaria, pollinosis, allergic conjunctivitis, atopic dermatitis, colitis ulcerosa, alimentary allergy, etc.
-
公开(公告)号:JPS63146881A
公开(公告)日:1988-06-18
申请号:JP29718287
申请日:1987-11-25
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: SHIOKAWA YOICHI , NAGANO MASANOBU , ITANI HIROMICHI
IPC: C07D471/04 , A61K31/44 , A61P1/04 , C07D20060101
Abstract: NEW MATERIAL:The compound of formula I [R is lower alkynyl (oxy lower alkyl) or N,N-di-lower alkylamine lower alkynyl; R is lower alkyl; R is cyano, trihalo-lower alkyl, carbamoyl, protected amino, (protected) COOH, OH, (protected) hydroxy-lower alkyl, substituted ar-lower alkyl, etc.; R is H or lower alkyl] and its salt. EXAMPLE:8-(2-Methoxycabonylamine-6-methylbenzyloxy)-2-methyl-3-(2-prop ynyl) imidazo[1,2-1]pyridine. USE:An antiulcer agent. PREPARATION:A compound of formula II or its salt is made to react with a compound of formula III or its reactive derivative at the OH group.
-
-
-
-
-
-
-
-
-